Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
08:00am, Wednesday, 05'th Jun 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the continued expansion of its injectables portfolio with six new in
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
04:05pm, Wednesday, 22'nd May 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California.
Amneal to Participate at Upcoming Investor Conference
04:05pm, Wednesday, 22'nd May 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Participate at Upcoming Investor Conference.
Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript
01:37pm, Friday, 03'rd May 2024
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX ) Q1 2024 Results Earnings Conference Call May 3, 2024 8:30 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - President and Co
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
11:00am, Friday, 03'rd May 2024
Amneal Pharmaceuticals said on Friday it had reached a deal valued at more than $270 million to resolve claims it helped fuel the deadly U.S. opioid epidemic, becoming the latest drug company to settl
Amneal (AMRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:36am, Friday, 03'rd May 2024
Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street e
Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates
08:11am, Friday, 03'rd May 2024
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.12 per share a year ago.
Amneal Reports First Quarter 2024 Financial Results
06:00am, Friday, 03'rd May 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--AMNEAL REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS.
California teams with Amneal Pharma for cheaper, generic version of Narcan
10:48pm, Monday, 29'th Apr 2024
SACRAMENTO, Calif. — California will soon begin selling its own generic version of Narcan — the drug that can save someone's life during an opioid overdose — under a deal announced Monday by Dem
Strength Seen in Amneal (AMRX): Can Its 12.0% Jump Turn into More Strength?
06:51am, Thursday, 25'th Apr 2024
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine
08:00am, Tuesday, 16'th Apr 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine.
Amneal to Report First Quarter 2024 Results on May 3, 2024
08:00am, Wednesday, 10'th Apr 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Report First Quarter 2024 Results on May 3, 2024.
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
04:05pm, Thursday, 28'th Mar 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal to Ring the Nasdaq Closing Bell on April 2, 2024.
Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension
04:05pm, Monday, 25'th Mar 2024
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension.
Amneal (AMRX) Stock Jumps 7.3%: Will It Continue to Soar?
07:16am, Wednesday, 20'th Mar 2024
Amneal (AMRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
